Pinnacle Biologics Appoints James L. Foght PhD to the Board of Directors
Dr. Foght has over 40 years experience in the healthcare and life science industries. He was a co-founder of DuPont Pharmaceuticals and the founder and President of Vector Securities International, a premier investment banking firm specializing in life sciences. He is currently chairman of the Board of Directors of Illinois Ventures LLC, a premier seed and early technology investment firm that commercializes technologies from the University of Illinois and other Midwestern universities. He also holds many advisory positions, and he is board member of the Illinois Emerging Technology Funds, Chairman of PharmaIn Inc. and a former board member at Cambridge Antibody Technology (UK), Acrux Limited (Melbourne, Australia) and Advisory Board Member for Ovation Pharmaceuticals (now Lundbeck).
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.